OSR (OSRH) Stock: Buy, Sell, or Hold?
OSRH - OSR Holdings, Inc. Common Stock
$0.12
-0.13 (-53.40%)
▼
5d:
-72.91%
30d:
-73.1%
90d:
-76.46%
WAIT
LOW Confidence
Analysis Updated: Aug 25, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When OSRH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: OSRH is down 72.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: OSRH is down 72.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: OSRH is currently trading at $0.12, which is considered fair based on recent price action.
Technical Outlook: Technically, OSRH is in a strong downtrend. Immediate support is located at $0.08, while resistance sits at $0.84. Short-term momentum is weak, with the stock down 53.4% recently.
Market Sentiment: OSRH scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+8483.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSRH is in a strong downtrend. Immediate support is located at $0.08, while resistance sits at $0.84. Short-term momentum is weak, with the stock down 53.4% recently.
Market Sentiment: OSRH scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+8483.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
39.5%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (33/100)
- BEARISH: Downward momentum (-53.4%)
- BULLISH: Trading 8483.7% below Wall St target ($10.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Support & Resistance Levels
Support Level
$0.08
Resistance Level
$0.84
Current Trend
Strong Downtrend
Technical data as of
Aug 25, 2026
Fundamental Context
Wall Street Target
$10.00
(+8483.7%)
Revenue Growth (YoY)
-72.2%
Share & Embed Analysis
Last updated: October 22, 2026 8:43 PM ET
Data refreshes hourly during market hours. Next update: 9:43 PM
Data refreshes hourly during market hours. Next update: 9:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSRH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 61 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 66 BUY |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 64 BUY |
